Cargando…

Periocular basal cell carcinoma - clinical perspectives

Basal cell carcinoma (BCC) as a non-melanoma skin cancer type is the most common malignant tumor throughout the world. The incidence is higher in age over 60. The intense of exposure to ultraviolet radiation is one of the known risk factors. Over 50% of BCC of the periocular region initially occur o...

Descripción completa

Detalles Bibliográficos
Autores principales: Furdova, Alena, Kapitanova, Karolina, Kollarova, Alexandra, Sekac, Juraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204832/
https://www.ncbi.nlm.nih.gov/pubmed/32395200
http://dx.doi.org/10.4081/oncol.2020.420
_version_ 1783530129634361344
author Furdova, Alena
Kapitanova, Karolina
Kollarova, Alexandra
Sekac, Juraj
author_facet Furdova, Alena
Kapitanova, Karolina
Kollarova, Alexandra
Sekac, Juraj
author_sort Furdova, Alena
collection PubMed
description Basal cell carcinoma (BCC) as a non-melanoma skin cancer type is the most common malignant tumor throughout the world. The incidence is higher in age over 60. The intense of exposure to ultraviolet radiation is one of the known risk factors. Over 50% of BCC of the periocular region initially occur on the lower lid and inner angle. Literature review of treatment options for basal cell carcinoma, which consist of surgery, or combined techniques plus vismodegib, radiotherapy and imiquimod. The first consideration for treatment of periocular BCC is radical surgical excision using Mohs micrographic technique. Functional and esthetic outcome in patients are important after clear excisions and reconstruction should be carefully considered. Radical exenteration is considered in the case of orbital invasion of high-risk aggressive BCC.
format Online
Article
Text
id pubmed-7204832
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-72048322020-05-11 Periocular basal cell carcinoma - clinical perspectives Furdova, Alena Kapitanova, Karolina Kollarova, Alexandra Sekac, Juraj Oncol Rev Review Basal cell carcinoma (BCC) as a non-melanoma skin cancer type is the most common malignant tumor throughout the world. The incidence is higher in age over 60. The intense of exposure to ultraviolet radiation is one of the known risk factors. Over 50% of BCC of the periocular region initially occur on the lower lid and inner angle. Literature review of treatment options for basal cell carcinoma, which consist of surgery, or combined techniques plus vismodegib, radiotherapy and imiquimod. The first consideration for treatment of periocular BCC is radical surgical excision using Mohs micrographic technique. Functional and esthetic outcome in patients are important after clear excisions and reconstruction should be carefully considered. Radical exenteration is considered in the case of orbital invasion of high-risk aggressive BCC. PAGEPress Publications, Pavia, Italy 2020-04-30 /pmc/articles/PMC7204832/ /pubmed/32395200 http://dx.doi.org/10.4081/oncol.2020.420 Text en ©Copyright: the Author(s) http://creativecommons.org/licenses/by-nc/4.0/ This work is licensed under a Creative Commons Attribution NonCommercial 4.0 License (CC BY-NC 4.0).
spellingShingle Review
Furdova, Alena
Kapitanova, Karolina
Kollarova, Alexandra
Sekac, Juraj
Periocular basal cell carcinoma - clinical perspectives
title Periocular basal cell carcinoma - clinical perspectives
title_full Periocular basal cell carcinoma - clinical perspectives
title_fullStr Periocular basal cell carcinoma - clinical perspectives
title_full_unstemmed Periocular basal cell carcinoma - clinical perspectives
title_short Periocular basal cell carcinoma - clinical perspectives
title_sort periocular basal cell carcinoma - clinical perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204832/
https://www.ncbi.nlm.nih.gov/pubmed/32395200
http://dx.doi.org/10.4081/oncol.2020.420
work_keys_str_mv AT furdovaalena periocularbasalcellcarcinomaclinicalperspectives
AT kapitanovakarolina periocularbasalcellcarcinomaclinicalperspectives
AT kollarovaalexandra periocularbasalcellcarcinomaclinicalperspectives
AT sekacjuraj periocularbasalcellcarcinomaclinicalperspectives